Osborne Clarke advises TiGenix on intended €520 million acquisition by Takeda
International legal practice Osborne Clarke is advising TiGenix, an advanced biopharmaceutical company listed on Euronext Brussels and NASDAQ (TIG), in...
Published on
15/01/2018
Read time
1m